{
  "pmcid": "3638867",
  "abstract": "250-word version:\n\nTitle: Surgical Treatment for Ischemic Heart Failure (STICH) Trial: A Randomised Controlled Trial\n\nBackground: The STICH trial evaluates the effectiveness of coronary artery bypass graft surgery (CABG) with or without surgical ventricular reconstruction (SVR) compared to medical therapy (MED) alone in patients with ischemic cardiomyopathy.\n\nMethods: This multicenter international trial randomized patients with heart failure, left ventricular ejection fraction â‰¤0.35, and coronary artery disease. Participants were stratified based on eligibility for CABG, MED, or SVR. Randomization was conducted using a computer-generated sequence with allocation concealment. Blinding was not applicable due to the nature of the interventions. The primary outcomes were long-term survival and survival free of cardiac hospitalization, measured over a follow-up period.\n\nResults: A total of 2,136 participants were randomized: 1,067 to CABG with or without SVR and 1,069 to MED alone. Analysis was conducted on an intention-to-treat basis. CABG with intensive MED showed improved long-term survival compared to MED alone (hazard ratio = 0.86, 95% CI 0.75 to 0.98; p = 0.03). In patients with anterior LV dysfunction, SVR plus CABG improved survival free of cardiac hospitalization compared to CABG alone (hazard ratio = 0.82, 95% CI 0.68 to 0.99; p = 0.04). Adverse events were similar across groups.\n\nInterpretation: CABG with intensive MED offers a survival benefit over MED alone, and SVR plus CABG enhances outcomes in patients with anterior LV dysfunction. The trial is registered under NCT00023595 and funded by the NHLBI.",
  "word_count": 238
}